The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
The Eczema Area and Severity Index – a practical guide
Open accessAbstract
ABSTRACT: Atopic dermatitis is a chronic inflammatory skin condition that affects approximately 18 million people in the United States. Assessing the extent and severity of atopic dermatitis is critical for determining baseline disease burden and treatment effectiveness for both investigators and clinicians. Considerable efforts over the past several decades have been made in developing a highly validated instrument called the Eczema Area and Severity Index (EASI). Although several guides exist for the EASI, questions continue to arise regarding its use and interpretation. This review was developed to serve as the definitive guide for the EASI and to address commonly asked questions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, erythema, a common marker of inflammation, is frequently underestimated and may appear more violaceous and grey in individuals with darker skin tone.72,73”
From Assessing the performance of artificial intelligence models in evaluating inflammatory skin disease severity: a systematic review and meta-analysis (2025) · cites this paper as [72]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis
Hanifin, J. M., Thurston, M., Omoto, M., Cherill, R., Tofte, S. J., Graeber, M., & Evaluator Group, T. E. (2001) · Experimental Dermatology · doi:10.1034/j.1600-0625.2001.100102.x · Cited by 1,200
Self-citationSchmitt, J., Spuls, P. I., Thomas, K. S., Simpson, E., Furue, M., Deckert, S., Dohil, M., Apfelbacher, C., Singh, J. A., Chalmers, J., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.07.043 · Cited by 319
Self-citationPapp, K. A., Szepietowski, J. C., Kircik, L., Toth, D. P., Eichenfield, L. F., Leung, D. Y. M., Forman, S. B., Venturanza, M. E., Sun, K., Kuligowski, M. E., et al. (2021) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2021.04.085 · Cited by 314
Self-citationChopra, R., Vakharia, P. P., Sacotte, R. M., Patel, N., Immaneni, S., White, T., Kantor, R. W., Hsu, D. Y., & Silverberg, J. I. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15641 · Cited by 302
Leshem, Y. A., Hajar, T., Hanifin, J. M., & Simpson, E. L. (2015) · British Journal of Dermatology · doi:10.1111/bjd.13662 · Cited by 295
Self-citationAssessment of clinical signs of atopic dermatitis: A systematic review and recommendation
Schmitt, J. M., Langan, S., Deckert, S., Svensson, Å., von Kobyletzki, L., Thomas, K. S., & Spuls, P. I. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.07.008 · Cited by 295
Rehal, B., & Armstrong, A. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017520 · Cited by 168
Ben‐Gashir, M., Seed, P. T., & Hay, R. J. (2002) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2002.04965.x · Cited by 143
Eczema area and severity index (EASI): A new tool to evaluate atopic dermatitis
Tofte, S. J. (1998) · Journal of the European Academy of Dermatology and Venereology · doi:10.1016/s0926-9959(98)95291-6 · Cited by 95
Bożek, A., & Reich, A. (2017) · Dermatology · doi:10.1159/000472711 · Cited by 74
Cited by
Sorted by citations
Guttman‐Yassky, E., Renert‐Yuval, Y., & Brunner, P. M. (2025) · The Lancet · doi:10.1016/s0140-6736(24)02519-4 · Cited by 357
Afshari, M., Koláčková, M., Rosecká, M., Čelakovská, J., & Krejsek, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1361005 · Cited by 156
Atopic Dermatitis: Disease Features, Therapeutic Options, and a Multidisciplinary Approach
Lugović‐Mihić, L., Meštrović-Štefekov, J., Potočnjak, I., Cindrić, T., Ilić, I., Lovrić, I., Skalicki, L., Bešlić, I., & Pondeljak, N. (2023) · Life · doi:10.3390/life13061419 · Cited by 69
Blockage of the IL-31 Pathway as a Potential Target Therapy for Atopic Dermatitis
Orfali, R. L., & Aoki, V. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020577 · Cited by 52
Laska, J., Tota, M., Łacwik, J., Sędek, Ł., & Gomułka, K. (2024) · Cells · doi:10.3390/cells13161398 · Cited by 52
Silverberg, J. I., Rosmarin, D. M., Chovatiya, R., Bieber, T. R. M., Schleicher, S., Beck, L. A., Gooderham, M., Chaudhry, S., Fanton, C. P., Yu, D., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53384-1 · Cited by 46
Abdel-Mageed, H. M. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01642-z · Cited by 45
Wang, Y., Hou, J., Tsui, J. C.-C., Wang, L., Zhou, J., Chan, U. K., Lo, C. J. Y., Siu, P. L. K., Loo, S. K. F., & Tsui, S. K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612856 · Cited by 39
Alska, E., Łaszczych, D., Napiórkowska-Baran, K., Szymczak, B., Rajewska, A., Rubisz, A. E., Romaniuk, P., Wrzesień, K., Mućka, N., & Bartuzi, Z. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14041079 · Cited by 36
The Aryl Hydrocarbon Receptor (AHR): Peacekeeper of the Skin
Dawe, H. R., & Meglio, P. D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041618 · Cited by 37
Fukushima‐Nomura, A., Kawasaki, H., Yashiro, K., Obata, S., Tanese, K., Ebihara, T., Saeki, H., Etoh, T., Hasegawa, T., Yazaki, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59340-x · Cited by 33
Yang, J., Li, D., Sun, S., Liu, D., Wang, Y., Liu, X., Zhou, B., Nie, W., Li, L., Wang, Y., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111867 · Cited by 25
Shen, S., Qu, X., Liu, Y., Wang, M., Zhou, H., & Xia, H. (2024) · Molecules · doi:10.3390/molecules29071566 · Cited by 25
Ramessur, R., Dand, N., Langan, S., Saklatvala, J. R., Fritzsche, M.-C., Holland, S., Arents, B. W. M., McAteer, H., Proctor, A., McMahon, D., et al. (2024) · British Journal of Dermatology · doi:10.1093/bjd/ljae080 · Cited by 22
Chovatiya, R., Ribero, S., Wollenberg, A., Park, C. O., Silvestre, J. F., Hong, H., Sénéschal, J., Saeki, H., Thyssen, J. P., Øland, C. B., et al. (2025) · American Journal of Clinical Dermatology · doi:10.1007/s40257-025-00931-1 · Cited by 23
Gan, C., Mahil, S. K., Pink, A., & Rodrigues, M. A. (2023) · Clinical and Experimental Dermatology · doi:10.1093/ced/llad162 · Cited by 22
Thyssen, J. P., Werfel, T., Barbarot, S., Hunter, H. J. A., Pierce, E. J., Sun, L., Cirri, L., Buchanan, A. S., Lu, N., & Wollenberg, A. (2023) · Journal of Dermatological Treatment · doi:10.1080/09546634.2023.2190430 · Cited by 19
Simpson, E. L., de Bruin-Weller, M. S., Hong, H., Staumont-Sallé, D., Blauvelt, A., Eyerich, K., Gooderham, M., Shahriari, M., Mallbris, L., Atwater, A. R., et al. (2024) · Dermatology and Therapy · doi:10.1007/s13555-024-01158-4 · Cited by 21
Self-citationGorelick, J., Nguyen, A., Schneider, S. K. R., Martel, B. C., Madsen, D. E., & Armstrong, A. W. (2025) · American Journal of Clinical Dermatology · doi:10.1007/s40257-024-00913-9 · Cited by 18
Soares, G. B., Orfali, R. L., Averbach, B. L., Yosipovitch, G., & Aoki, V. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12103419 · Cited by 18
Topical Treatments in Atopic Dermatitis: An Expansive Review
Lazar, M., Zhang, A. D., & Vashi, N. A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13082185 · Cited by 17
Measuring Signs of Atopic Dermatitis in Clinical Practice
Jacobson, M. E., Leshem, Y. A., Apfelbacher, C., Spuls, P. I., Gerbens, L. A. A., Thomas, K. S., Williams, H. C., Katoh, N., Howells, L., Schmitt, J. M., et al. (2024) · JAMA Dermatology · doi:10.1001/jamadermatol.2024.1162 · Cited by 16
Self-citationGómez-Farto, A., Jiménez-Escobar, A. L., Pérez-González, N., Castán, H., Clares, B., Arias‐Santiago, S., & Montero‐Vílchez, T. (2024) · Gels · doi:10.3390/gels10060370 · Cited by 13
Blauvelt, A., Reckleff, J., Zhao, Y., Clark, M., Kosa, K., Harris, N., Esfandiari, E., Martin, S. A., Whalley, D., & Guttman‐Yassky, E. (2024) · British Journal of Dermatology · doi:10.1093/bjd/ljae346 · Cited by 13
A systematic review of guidelines for the management of atopic dermatitis in children
Deva, M., Netting, M., Weidinger, J., Brand, R., Loh, R., & Vale, S. (2024) · World Allergy Organization Journal · doi:10.1016/j.waojou.2024.100989 · Cited by 13
Jacobson, M. E., Morimoto, R. Y., Leshem, Y. A., Howells, L., Williams, H. C., Grinich, E. E., Gerbens, L. A. A., Spuls, P. I., Schmitt, J., Staley, B., et al. (2024) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.20248 · Cited by 12
Self-citationKim, Y., Seo, G., Koopman, J. J. E., & Yee, J. (2025) · Clinical & Experimental Allergy · doi:10.1111/cea.70125 · Cited by 12
Hyperactivation of sympathetic nerves fuels basophil infiltration in atopic dermatitis
Xie, X., Jiang, W., Lun, L., Huang, X., Xu, R., Li, X., Zhan, J., Xie, Y., Shen, M., Li, X., et al. (2026) · Immunity · doi:10.1016/j.immuni.2026.01.010 · Cited by 12
Ethnicity, Race and Skin Color: Challenges and Opportunities for Atopic Dermatitis Clinical Trials
Bissonnette, R., Jankićević, J., Proulx, É. S., & Maari, C. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12113805 · Cited by 13
Wollenberg, A., Simon, D., Kulthanan, K., Figueras‐Nart, I., Misery, L., Tangsirisap, N., Spina, L., Lu, N., Grond, S., & Eyerich, K. (2023) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.19669 · Cited by 12
Advancements in Allergen Immunotherapy for the Treatment of Atopic Dermatitis
Guo, B.-C., Wu, K., Chen, C., Lin, W.-Y., Chang, Y., Lin, M.-J., & Wu, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021316 · Cited by 12
Potential Aspects of the Use of Cytokines in Atopic Dermatitis
Krupka‐Olek, M., Bożek, A., Aebisher, D., Bartusik‐Aebisher, D., Cieślar, G., & Kawczyk‐Krupka, A. (2024) · Biomedicines · doi:10.3390/biomedicines12040867 · Cited by 13
Silverberg, J. I., Eichenfield, L. F., Blauvelt, A., Irvine, A. D., Guttman‐Yassky, E., Langley, R. G. B., Warren, R. B., French, L. E., Felding, J., Weiss, A., et al. (2025) · British Journal of Dermatology · doi:10.1093/bjd/ljae507 · Cited by 12
Self-citationvan der Rijst, L. P., van Luijk, C. M., van der Kamp, S., Zuithoff, N. P. A., de Boer, J. H., de Bruin-Weller, M. S., & de Graaf, M. (2025) · Clinical & Experimental Allergy · doi:10.1111/cea.70025 · Cited by 13
Abrocitinib versus dupilumab: Impact on skin barrier function and proteomics in atopic dermatitis
Chang, J., Huang, X., Jiang, W., Lun, L., Liu, W., Xu, R., Tang, R., Xie, X., Zhai, W., Su, H., et al. (2025) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2025.04.027 · Cited by 12
Outlining the skin-homing and circulating CLA+NK cells in patients with severe atopic dermatitis
de Lima, J. F., Teixeira, F. M. E., Ramos, Y. Á. L., de Carvalho, G. C., Branco, A. C. C. C., Pereira, N. V., Sotto, M. N., Aoki, V., Sato, M. N., & Orfali, R. L. (2024) · Scientific Reports · doi:10.1038/s41598-024-53224-8 · Cited by 11
Drug Survival of Dupilumab, Methotrexate, and Cyclosporine A in Children With Atopic Dermatitis
van der Rijst, L. P., Kamphuis, E., Schuttelaar, M. L. A., Hurmuz, R., Seyger, M. M. B., Caron, A. G. M., Zuithoff, N. P. A., Nguyen, N. T., Kamsteeg, M., de Bruin-Weller, M. S., et al. (2024) · JAMA Dermatology · doi:10.1001/jamadermatol.2024.3717 · Cited by 11
Guttman‐Yassky, E., Esfandiari, E., Mano, H., Arai, T., Irvine, A. D., Cork, M. J., Kabashima, K., Chong, C., & Simpson, E. L. (2024) · Archives of Dermatological Research · doi:10.1007/s00403-024-03426-x · Cited by 11
Self-citationTargeting Intracellular Pathways in Atopic Dermatitis with Small Molecule Therapeutics
Nițulescu, G., Olaru, O. T., Andrei, C., Nitulescu, G. M., & Zanfirescu, A. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47080659 · Cited by 12
Greenfield, D. A., Feizpour, A., & Evans, C. L. (2023) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2023.01.026 · Cited by 9
Ragamin, A., Schappin, R., Nguyen, N. T., Nouwen, A. E. M., Hoekstra, L. F., Schuttelaar, M. L. A., & Pasmans, S. G. M. A. (2023) · JAAD International · doi:10.1016/j.jdin.2023.07.019 · Cited by 13
Simpson, E. L., Blauvelt, A., Silverberg, J. I., Cork, M. J., Katoh, N., Mark, T., Schneider, S. K. R., & Wollenberg, A. (2023) · American Journal of Clinical Dermatology · doi:10.1007/s40257-023-00817-0 · Cited by 12
Self-citationDiagnosis, assessment and management of atopic dermatitis in children with skin of colour
Gan, C., Brand, R., Foster, R. S., Weidinger, J., & Rodrigues, M. (2023) · Australian Journal of General Practice · doi:10.31128/ajgp-01-23-6684 · Cited by 10
Almoghayer, I. H. I., Soomro, A. M., Dev, S., Turesh, M., Kumar, A., Kumar, R., Meghjiani, A., Mir, S. L., Hassaan, M., Qureshi, R., et al. (2024) · Frontiers in Allergy · doi:10.3389/falgy.2024.1486271 · Cited by 9
Grieco, T., Paolino, G., Moliterni, E., Chello, C., Sernicola, A., Egan, C. G., Morelli, M., Nannipieri, F., Battaglia, S., Accoto, M., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010211 · Cited by 9
Scala, E., Madonna, S., ABENI, D. D., Cecchi, L., Cocuroccia, B., Dattolo, A., Moretta, G., Provini, A., Russo, F., Sordi, D., et al. (2024) · Allergy · doi:10.1111/all.16377 · Cited by 9
Cai, Z. R., Kim, J., Rezaei, S. J., Chen, M. L., Touma, F., Zhu, C., Onyeka, S., Fonjungo, F., Omiye, J. A., Krakowski, I., et al. (2025) · British Journal of Dermatology · doi:10.1093/bjd/ljaf250 · Cited by 8
“72,73 Therefore, exploring the use of objective reference standards such as colorimetry could be valuable for enhancing AI performance in disease severity assessments.”
Jin, J. Q., Hong, J. A., Elhage, K. G., Braun, M., Spencer, R. K., Chung, M., Yeroushalmi, S., Hadeler, E. K., Mosca, M., Bartholomew, E., et al. (2023) · Frontiers in Digital Health · doi:10.3389/fdgth.2023.1228503 · Cited by 8
Kallipolitis, A., Μούτσελος, Κ., Zafeiriou, A., Andreadis, S. T., Matonaki, A., Stavropoulos, T. G., & Maglogiannis, I. G. (2025) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-024-02843-2 · Cited by 9
Behavioral disorders in children and adolescents with atopic dermatitis
Moraes, M. M., Vaz, F. P. C., Roque, R., Mallozi, M. C., Solé, D., & Wandalsen, G. F. (2023) · Jornal de Pediatria · doi:10.1016/j.jped.2023.08.006 · Cited by 9
Barei, F., Zussino, M., Tavecchio, S., Angileri, L., Rizzo, A., Calzari, P., Marzano, A. V., & Ferrucci, S. M. (2024) · Pharmaceuticals · doi:10.3390/ph17010117 · Cited by 8
Carrascosa, J. M., Narcisi, A., Nomura, T., Ständer, S., Vestergaard, C., Sabatino, S., Grond, S., Koppelhus, U., Elrayes, M., Chen, Y.-F., et al. (2024) · Dermatology and Therapy · doi:10.1007/s13555-024-01171-7 · Cited by 8
Emollient application from birth to prevent eczema in high-risk children: the BEEP RCT
Bradshaw, L. E., Wyatt, L. A., Brown, S., Haines, R., Montgomery, A. A., Perkin, M. R., Sach, T., Lawton, S., Flohr, C., Ridd, M. J., et al. (2024) · Health Technology Assessment · doi:10.3310/rhdn9613 · Cited by 8
Self-citationPaller, A. S., Marcoux, D., Ramien, M., Baselga, E., Carvalho, V. O., Ardusso, L., de Graaf, M., Pasmans, S. G. M. A., Toledo-Bahena, M. E., Rubin, C., et al. (2025) · American Journal of Clinical Dermatology · doi:10.1007/s40257-025-00962-8 · Cited by 7
McCarthy, R. L., Tawfik, S. S., Theocharopoulos, I. C., Atkar, R., McDonald, B., Dhoat, S., Hughes, A., Thomas, B., & O’Toole, E. A. (2024) · Skin Health and Disease · doi:10.1002/ski2.358 · Cited by 9
Zeidler, C., Ständer, S., Rhoten, S. E., Wratten, S., Zhang, D., Msihid, J., Brookes, E., Thomas, R. B., & Bahloul, D. (2024) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.19961 · Cited by 7
Recent insights into comorbidities in atopic dermatitis
Gewiss, C., & Augustin, M. (2023) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2023.2181790 · Cited by 7
Ragamin, A., Schappin, R., de Graaf, M., Tupker, R. A., Fieten, K. B., van Mierlo, M. M. F., Bronner, M. B., Romeijn, G. L. E., Sloot, M. M., Boesjes, C. M., et al. (2023) · British Journal of Dermatology · doi:10.1093/bjd/ljad437 · Cited by 7
Thomas, K. S., Howells, L., Leshem, Y. A., Simpson, E. L., Apfelbacher, C., Spuls, P. I., Gerbens, L. A. A., Jacobson, M. E., Katoh, N., Williams, H. C., et al. (2023) · British Journal of Dermatology · doi:10.1093/bjd/ljad497 · Cited by 7
Self-citationForsyth, A., Prajapati, S., Frasier, K. M., Kriebel, C., Jackson, T., Batista, R. R., Jean, F., & Ezekwe, U. (2025) · Cureus · doi:10.7759/cureus.94930 · Cited by 9
Reich, A., Blauvelt, A., Weidinger, S., Shi, V. Y., Katoh, N., Lynde, C. W., Gao, X., Armstrong, N. M., Bernigaud, C., & Rahawi, K. (2025) · Dermatology and Therapy · doi:10.1007/s13555-025-01609-6 · Cited by 6
Sivesind, T. E., Oganesyan, A., Bosma, G., Hochheimer, C. J., Schilling, L. M., & Dellavalle, R. P. (2023) · JMIR Dermatology · doi:10.2196/41194 · Cited by 6
Knöps, E., Spuls, P. I., Duijnhoven, R. G., Dijkgraaf, M. G. W., van Barreveld, M., Arents, B. W. M., van Enst, A., Garritsen, F. M., Merkus, M. P., Middelkamp-Hup, M. A., et al. (2024) · Trials · doi:10.1186/s13063-024-08334-z · Cited by 6
Kamp, E., Ascott, A., & George, S. M. (2025) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2025.02.001 · Cited by 9
Exploring the Interplay: Obesity, Lipid Metabolism, and Clinical Manifestations in Atopic Dermatitis
Chu, H., Jung, Y. W., Kim, S. M., Bae, B. G., Bae, J. M., Kim, L. K., Lee, K. H., & Park, C. O. (2024) · Annals of Dermatology · doi:10.5021/ad.23.151 · Cited by 5
Clinical course of atopic dermatitis after dupilumab discontinuation: a multicentre real-world study
Barei, F., Macchi, S., Calzari, P., Ribero, S., Ortoncelli, M., Foti, C., Balato, A., Brizzi, E. V. D., Peris, K., Gori, N., et al. (2025) · Clinical and Experimental Dermatology · doi:10.1093/ced/llaf275 · Cited by 5
Weidinger, S., Aoki, V., Dhar, S., Dlova, N. C., Kabashima, K., Ma, L., Flohr, C., & Irvine, A. D. (2026) · Nature Reviews Disease Primers · doi:10.1038/s41572-026-00703-z · Cited by 11
Yew, Y. W., Alagappan, U., Aw, D. C., Chandran, S., Choo, K. J., Chu, R., Koh, H. Y., Koh, M. J. A., Lee, S. X., Neoh, C. Y., et al. (2024) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.2024158 · Cited by 5
Atopic dermatitis epidemiological research methodology: a global scoping review
Chang, C.-Y., Chan, K., Chen, H.-C., Lai, C.-C., Poole, K., Allen, P., Chi, C., Prieto‐Merino, D., Vestergaard, C., Yew, Y. W., et al. (2025) · British Journal of Dermatology · doi:10.1093/bjd/ljaf238 · Cited by 5
Binsaleh, A. Y., Bahaa, M. M., El-Masry, T. A., Elberri, E. I., Kotkata, F. A., El‐Khateeb, E., Kamal, M., El‐samongy, M. A., Hamouda, A. O., Alghamdi, A. M., et al. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1399305 · Cited by 5
Consensus Recommendations for the Management of Atopic Dermatitis in the United Arab Emirates
Ameen, A., Aldhaheri, A. S., Reda, A. M., Alnaeem, A., Marzooqi, F. A., Albreiki, F., Ali, H. R., Dayem, H. A., Alnaqbi, J., Zaabi, M. A., et al. (2024) · Dermatology and Therapy · doi:10.1007/s13555-024-01247-4 · Cited by 6
Wang, D., Wang, W., Zhang, Q., Liu, C., Li, X., Zuo, K., Xie, Y., & Zhang, X. (2024) · Current Drug Delivery · doi:10.2174/0115672018315617240826133041 · Cited by 5
Shahin, A., Leshem, Y. A., Taieb, Y., Baum, S., Barzilai, A., Jeddah, D., Sharon, E., Koren, O., Tzach‐Nahman, R., Coppenhagen‐Glazer, S., et al. (2024) · International Dental Journal · doi:10.1016/j.identj.2024.10.003 · Cited by 5
Self-citationRanasinghe, S., Senarathne, S., Somaratne, V., Lacey, C. J., Jayakody, S., Wickramasinghe, A., Kahawita, I. P., Goto, H., Chatterjee, M., Lindoso, J. Â. L., et al. (2024) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0012393 · Cited by 4
Augustin, M., Bewley, A., Brüggen, M., de Bruin-Weller, M. S., Ezzedine, K., Ferrucci, S. M., Gkalpakiotis, S., Herranz, P., Johansson, E. K., Kampe, T., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-102155 · Cited by 4
Beltrami, E. J., Gronbeck, C., Jain, N. P., Hargis, G. R., Feng, H., Grant-Kels, J. M., & Sloan, B. (2023) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2023.07.001 · Cited by 4
Efficacy and Safety of Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Meta-Analysis
Meher, B. R., Mishra, A., Behera, B., & Ponnusamy, S. (2024) · Cureus · doi:10.7759/cureus.64488 · Cited by 4
Paller, A. S., González, M. E., Barnum, S., Jaeger, J., Shao, L., Ozturk, Z. E., & Korotzer, A. R. (2024) · Archives of Dermatological Research · doi:10.1007/s00403-024-03210-x · Cited by 4
Shin, S., Kim, Y. J., Kim, S. J., Kim, G. T., Lee, H., Kim, E. Y., Lee, S. H., Sohn, K., Kim, J. W., & Lee, J. S. (2024) · Scientific Reports · doi:10.1038/s41598-024-73951-2 · Cited by 4
Wang, J., Pereda, J., Du, C.-W., Chu, C., Christensen, M. O., Kežić, S., Jakaša, I., Thyssen, J. P., Satheesh, S. K., & Hwu, E. (2024) · GigaScience · doi:10.1093/gigascience/giae095 · Cited by 4
Evaluating the necessity of formal atopic dermatitis severity measurement tools in clinical practice
Buttar, B. A., Yi, R. C., Ruley, A. J., Fleischer, A. B., & Feldman, S. R. (2025) · Journal of Dermatological Treatment · doi:10.1080/09546634.2025.2469646 · Cited by 4
Wright, A. K., Swan, R., Xu, J., Lwin, S. M., Azrielant, S., Chateau, A. V., Ede, C., Sons, J. S., Gxolo, Z., Skenjana, A., et al. (2025) · British Journal of Dermatology · doi:10.1093/bjd/ljaf386 · Cited by 3
Ho, M. J., Sultana, R., Choo, K. J., & Lee, H. Y. (2025) · Dermatology · doi:10.1159/000548368 · Cited by 3
Chaturvedi, A. R., Zaveri, H., Patel, D. V., & Tof-O in AD Trial Investigators (2025) · Indian Journal of Dermatology · doi:10.4103/ijd.ijd_197_24 · Cited by 3
Xiong, F., Zhou, B., Huang, S., Li, J., Cao, Q., Jiang, M., Jia, Q., Shui, X., Li, S., Yi, X., et al. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-02086-1 · Cited by 3
Mathure, D. M., Bhise, V., Salunke, M. R., Borse, G., Ranpise, H. A., & Awasthi, R. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02144-2 · Cited by 3
Lebrikizumab off-therapy remission sustained up to 38 weeks in atopic dermatitis
Silverberg, J. I., Bieber, T. R. M., Eyerich, K., Armstrong, A. W., Nickoloff, B. J., Natalie, C. R., GALLO, G., Okragly, A. J., Wolf, E., Xu, C., et al. (2026) · Journal of Dermatological Treatment · doi:10.1080/09546634.2026.2636417 · Cited by 3
Zorko, M. S., Benko, M., Rakuša, M., & Zdravković, T. P. (2023) · Acta Dermatovenerologica Alpina Pannonica et Adriatica · doi:10.15570/actaapa.2023.26 · Cited by 3
Gut barrier integrity disruption in atopic dermatitis: truth or myth—a case–control study
Sayed, N. M. E., Riad, M. A., Taleb, R. S. Z., & Elmorsy, E. H. (2025) · Skin Health and Disease · doi:10.1093/skinhd/vzaf001 · Cited by 3
Sagara, N., Akashi, K., Sato, M., Nagao, M., & Katsunuma, T. (2025) · Pediatric Allergy and Immunology · doi:10.1111/pai.70076 · Cited by 3
Villa-González, J. M., Gonzalez-Hermosa, M. R., Alzaga, J. U., Blasco, R. P., Ibarrola, P. A., Atxutegi‐Ayesta, X., García, A. G., Aguirre, I. I., del Tánago, B. U. G., Ares, M. P., et al. (2025) · Dermatitis · doi:10.1089/derm.2025.0054 · Cited by 2
Li, J., Zhou, M., Li, Y., Wu, X., Li, X., Xie, X., & Xiong, L.-J. (2025) · Frontiers in Pediatrics · doi:10.3389/fped.2025.1612076 · Cited by 3
Meng, Y., Fan, J.-C., & Bian, W.-N. (2022) · Medicine · doi:10.1097/md.0000000000030237 · Cited by 3
Jamalyan, K. R., & Azaryan, H. G. (2024) · Advances in Dermatology and Allergology · doi:10.5114/ada.2023.135759 · Cited by 3
Porter, E., O’Connor, C., & Murphy, M. (2024) · Skin Health and Disease · doi:10.1002/ski2.372 · Cited by 3
Emerging drugs for the treatment of atopic dermatitis: a focus on phase 2 and phase 3 trials
Obed, O., Chong, A. C., Su, M., & Ong, P. Y. (2024) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2024.2345643 · Cited by 3
Zaslavsky, D. V., Barinova, A. N., Plavinskij, S. L., Zelianina, M. I., Zakharova, I. N., Berezhnaya, I. V., Shartanova, N. V., & Sidorovich, O. I. (2023) · Russian Journal of Skin and Venereal Diseases · doi:10.17816/dv122220 · Cited by 3
Vinpocetine, a phosphodiesterase 1 inhibitor, mitigates atopic dermatitis-like skin inflammation
Lee, J. H., Song, J. Y., Lee, S. H., Lee, Y., Hwang, K. T., & Lee, J.-Y. (2024) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2024.28.4.303 · Cited by 2
Augustin, M., Napolitano, M., Izu-Belloso, R., Kleyn, C. E., Sabatino, S., Grond, S., Otero-Asman, J. R., Liu, C., Reguiaï, Z., & Nomura, T. (2025) · Dermatology and Therapy · doi:10.1007/s13555-024-01330-w · Cited by 2
Lifestyle Factors in the Clinical Manifestation and Management of Atopic Dermatitis
Lam, K., & Agrawal, D. K. (2025) · Archives of Internal Medicine Research · doi:10.26502/aimr.0193 · Cited by 2
Metadata
- Authors
- Hanifin, J. M., Baghoomian, W., Grinich, E., Leshem, Y. A., Jacobson, M., & Simpson, E. L.
- Affiliations
- Oregon Health & Science University (US)
- Tel Aviv University (IL)
- Corresponding author
- Hanifin, Jon M.
- Baghoomian, Wenelia
- Grinich, Erin
- Jacobson, Michael
- Simpson, Eric Lawrence
- ORCID
- Venue
- Dermatitis
- Publisher
- SAGE Publications
- Published
- 2022-05
- Volume
- 33
- Issue
- 3
- Pages
- 187-192
- ISSN
- 1710-3568 (ISSN-L)
- 2162-5220
- PMC
- PMC9154300
- OpenAlex
- W4280586178
- Cited by
- 213
- References
- 12
- Citations by year
- 2026: 57 · 2025: 67 · 2024: 64 · 2023: 23 · 2022: 2
- FWCI
- 38.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Dermatitis (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- Eczema Area and Severity Index, atopic dermatitis, disease severity assessment, disease burden, patient-reported outcome measures
- MeSH terms
- Dermatitis, Atopic, Eczema, Humans, Severity of Illness Index, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
